SCHEMBL4458968

SCHEMBL4458968

O=C(O)/C(=C/c1ccccc1F)CC(=O)N1C[C@H]2CCCC[C@H]2C1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MITF O75030 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ HSP90AA1 P07900 1/20 0.39
▸ NPC1 O15118 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ C3AR1 Q16581 1/20 0.38
▸ FFAR1 O14842 1/20 0.36
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ HIF1A Q16665 1/20 0.35
▸ SCN9A Q15858 2/20 0.35
▸ SCN10A Q9Y5Y9 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4458970 1.00 MITF (0.39) MITFLMNAHSP90AA1NPC1MAPT
SCHEMBL4458965 1.00 MITF (0.39) MITFLMNAHSP90AA1NPC1MAPT
SCHEMBL4458977 1.00 MITF (0.39) MITFLMNAHSP90AA1NPC1MAPT
SCHEMBL4458969 1.00 MITF (0.39) MITFLMNAHSP90AA1NPC1MAPT
SCHEMBL9047597 0.87 NPC1 (0.41) LMNANPC1MAPTRAB9ASMN1; SMN2
SCHEMBL9047580 0.87 NPC1 (0.41) LMNANPC1MAPTRAB9ASMN1; SMN2
SCHEMBL9047609 0.87 NPC1 (0.41) LMNANPC1MAPTRAB9ASMN1; SMN2
SCHEMBL9047592 0.87 NPC1 (0.41) LMNANPC1MAPTRAB9ASMN1; SMN2
SCHEMBL9047586 0.87 NPC1 (0.41) LMNANPC1MAPTRAB9ASMN1; SMN2
SCHEMBL4463342 0.86 FFAR1 (0.36) SMN1; SMN2FFAR1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0507534-B1 Succinic acid compounds KISSEI PHARMACEUTICAL (JP) 1996-02-28 — — EP claimed
EP-1931359-A4 COMBINATION THERAPY FOR CONTROLLED CARBOHYDRATE DIGESTION ELIXIR PHARMACEUTICALS INC (US) 2009-04-01 — — EP disclosed
EP-1931359-A2 COMBINATION THERAPY FOR CONTROLLED CARBOHYDRATE DIGESTION Elixir Pharmaceuticals, Inc. (US) 2008-06-18 — — EP disclosed
WO-2007033292-A2 COMBINATION THERAPY FOR CONTROLLED CARBOHYDRATE DIGESTION ELIXIR PHARMACEUTICALS, INC. (US) 2007-03-22 — — WO disclosed
EP-0507534-B1 Succinic acid compounds KISSEI PHARMACEUTICAL (JP) 1996-02-28 — — EP disclosed
US-5202335-A Hypoglycemic, antidiabetic agents KISSEI PHARMACEUTICAL CO., LTD. (JP) 1993-04-13 — — US disclosed
EP-0507534-A1 Succinic acid compounds KISSEI PHARMACEUTICAL CO., LTD. (JP) 1992-10-07 — — EP disclosed
Send feedback